Eric Wang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Acute Myeloid Leukemia

Prognostic Factors

Ejection Fraction

Top Venues

Future oncology (London, England)

Biomarkers in medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Eric Wang, Mackenzie Henderson, Priyanka Yalamanchili, Jenilee Cueto, Zahidul Islam, Charles Dharmani, Maribel Salas
Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework. Biomarkers in medicine 18 (6) (2024)
Charles Dharmani, Oluwatosin Fofah, Eric Wang, Maribel Salas, Margaret Wooddell, Nora Tu, Jenny Tse, Aimee M Near, Gabriel Tinoco
Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA. Future oncology (London, England) (2024)
Eric Wang, Mackenzie Henderson, Priyanka Yalamanchili, Jenilee Cueto, Zahidul Islam, Charles Dharmani, Maribel Salas
Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework. Biomarkers in medicine 18 (6) (2024)
Eric Wang, Mackenzie Henderson, Priyanka Yalamanchili, Jenilee Cueto, Zahidul Islam, Charles Dharmani, Maribel Salas
Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework. Biomarkers in medicine (2024)
Charles Dharmani, Oluwatosin Fofah, Eric Wang, Maribel Salas, Margaret Wooddell, Nora Tu, Jenny Tse, Aimee M Near, Gabriel Tinoco
Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA. Future oncology (London, England) (2024)
Charles Dharmani, Oluwatosin Fofah, Eric Wang, Maribel Salas, Margaret Wooddell, Nora Tu, Jenny Tse, Aimee M Near, Gabriel Tinoco
Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA. Future oncology (London, England) 20 (16) (2024)
Charles Dharmani, Oluwatosin Fofah, Eric Wang, Maribel Salas, Margaret Wooddell, Nora Tu, Jenny Tse, Aimee M Near, Gabriel Tinoco
Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA. Future oncology (London, England) 20 (16) (2024)
Eric Wang, Mackenzie Henderson, Priyanka Yalamanchili, Jenilee Cueto, Zahidul Islam, Charles Dharmani, Maribel Salas
Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework. Biomarkers in medicine 18 (6) (2024)
Charles Dharmani, Eric Wang, Nora Tu, Oluwatosin Fofah, Jenilee Cueto, Maribel Salas, Yasser Mostafa Kamel
Elderly patients with acute myeloid leukemia who only receive supportive care in the Surveillance, Epidemiology and End Results-Medicare database: demographics, treatment patterns and outcomes. Future oncology (London, England) (2023)
Charles Dharmani, Eric Wang, Nora Tu, Maribel Salas, Yasser Mostafa Kamel
Characteristics and outcomes of elderly patients with acute myeloid leukemia who receive no treatment in the Surveillance, Epidemiology and End Results-Medicare database. Future oncology (London, England) (2023)
Charles Dharmani, Eric Wang, Maribel Salas, Colleen McCabe, Alvileen Diggs, Youngsook Choi, Jason Jiang, Vicki L Keedy
Turalio risk evaluation and mitigation strategy for treatment of tenosynovial giant cell tumor: framework and experience. Future oncology (London, England) 18 (13) (2022)